Is a complete SHE/300181 research report available?

Question

Accepted Answer

No complete published report is available for she/300181 (SHE/300181) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Volume
Market cap	9.9B
Revenue (ttm)	3.1B
Net income (ttm)	650.4M
EPS (ttm)	CN¥0.94
Shares out	693.2M
P/E (trailing)	15.2x
P/E (forward)	13.7x
Dividend	CN¥0.35 (2.51%)

Metric	Value
Country	China
Country code	CN
Employees	2,861
Employees Change	736%
Employees Change Percent	34.64
Enterprise value	CNY 10B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Industry PE	45.24
Isin	CNE100001096
Last refreshed	2026-07-30
Market cap	CNY 9.9B
Price	CNY 14.65
Price currency	CNY
Rev Per Employee	1,088,478x
Sector	Healthcare
Sector PE	39.11
Sector PE Fwd	22.14
Sic	2834
Symbol	she/300181
Website	https://zuoli.com

Metric	Value
Earnings Yield	6.59%
EV Earnings	15.35x
EV/EBIT	12.82x
EV/EBITDA	11.62x
EV/FCF	28.06x
EV/Sales	3.21x
FCF yield	3.61%
Forward P/E	13.68x
P/B ratio	2.82x
P/E ratio	15.19x
P/S ratio	3.17x
PE Ratio10 Y	66.1x
PE Ratio3 Y	20.64x
PE Ratio5 Y	24.83x

Metric	Value
EBIT Margin	25%
EBITDA Margin	27.45%
FCF margin	11.42%
Gross margin	62.09%
Gross Profit	CNY 1.9B
Gross Profit Growth	19.91%
Gross Profit Growth Q	14.15%
Gross Profit Growth3 Y	14.13%
Gross Profit Growth5 Y	18%
Net Income	CNY 650.4M
Net Income Growth	19.01%
Net Income Growth Q	10.18%
Net Income Growth Quarters	5%
Net Income Growth Years	7%
Net Income Growth3 Y	29.18%
Net Income Growth5 Y	39.83%
Pretax Margin	25.03%
Profit Margin	20.88%
Profit Per Employee	CNY 227,324
Profitable Quarters	CNY 25
Profitable Years	19
ROA	9.83
Roa5y	7.88
ROCE	21.29
ROE	19.81
Roe5y	15.24
ROIC	19.43
Roic5y	18.26

Metric	Value
Cagr10y	6.23%
Cagr15y	11.45%
Cagr1y	-21.91%
Cagr3y	12.48%
Cagr5y	16.42%
Div CAGR10	17.46%
Div CAGR3	5.27%
Div CAGR5	28.47%
EPS Growth	19.19
EPS Growth Q	10.18
EPS Growth Quarters	5
EPS Growth Years	7
EPS Growth3 Y	25.05
EPS Growth5 Y	36.17
FCF Growth3 Y	57.41%
FCF Growth5 Y	5.91%
OCF Growth	181.05%
OCF Growth10 Y	17.66%
OCF Growth3 Y	32.47%
OCF Growth5 Y	11.7%
Revenue Growth	14.1x
Revenue Growth Q	8.9x
Revenue Growth Quarters	24x
Revenue Growth Years	8x
Revenue Growth3 Y	18.71x
Revenue Growth5 Y	20.26x

SHE/300181 (SHE/300181)

Coverage state: Market snapshot only — no published research

Generate the first SHE/300181 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300181

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300181 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SHE/300181

Frequently asked questions

Metric	Value
Asset Turnover	CNY 0.63
Assets	CNY 5.3B
Cash	CNY 718.3M
Current Assets	CNY 2.6B
Current Liabilities	CNY 1.7B
Debt	CNY 766.5M
Debt EBITDA	CNY 0.89
Debt Equity	CNY 0.22
Debt FCF	CNY 2.15
Equity	CNY 3.5B
Interest Coverage	49.3
Liabilities	CNY 1.8B
Long Term Assets	CNY 2.7B
Long Term Liabilities	CNY 162.4M
Net Cash	CNY -48.2M
Net Cash By Market Cap	CNY -0.49
Net Debt EBITDA	CNY 0.06
Net Debt Equity	CNY 0.01
Net Debt FCF	CNY 0.14
Tangible Book Value	CNY 2.8B
Tangible Book Value Per Share	CNY 4.07
WACC	4.81

Metric	Value
Current ratio	1.55
Inventory Turnover	2.27
Net Working Capital	CNY 923.9M
Quick ratio	1.19
Working Capital	CNY 923.2M
Working Capital Turnover	CNY 2.9

Metric	Value
Buyback Yield	0.16%
Dividend Growth	-41.67%
Dividend Growth Years	5%
Dividend per share	CNY 0.35
Dividend Years	15
Dividend Yield	2.51%
Ex Div Date	2026-05-28
Last Dividend	CNY 0.35
Payout Frequency	Annual
Payout Ratio	64.17%

Metric	Value
10Y total return	83.01%
1Y total return	-21.9%
200-day SMA	16.01
3Y total return	42.31%
50-day SMA	13.83
50-day SMA vs 200-day SMA	50under200
5Y total return	113.88%
All Time High	21.07
All Time High Change	-32.46%
All Time High Date	2025-08-19
All Time Low	2.63
All Time Low Change	441.27%
All Time Low Date	2011-06-22
ATR	0.61
Beta	0.14
Beta1y	0.13
Beta2y	0.28
Ch YTD	-11.94
High	14.66
High52	21.07
High52 Date	2025-08-19
High52ch	-30.47%
Low	13.98
Low52	12.3
Low52 Date	2026-06-22
Low52ch	19.11%
Ma50ch	2.93%
Price vs 200-day SMA	-11.13%
RSI	51.69
RSI Monthly	45.13
RSI Weekly	43.84
Sharpe ratio	-0.74x
Sortino ratio	-0.9
Total Return	2.66%
Tr YTD	-9.72
Tr15y	408.15%
Tr1m	10.65%
Tr1w	-0.84%
Tr3m	-4.15%

Metric	Value
Operating Income	CNY 778.4M
Operating Income Growth	23.14
Operating Income Growth Q	12.86
Operating Income Growth3 Y	30.74
Operating Income Growth5 Y	37.58
Operating margin	25

Metric	Value
Float	533,310,858%
Net Borrowing	236,791,195
Shares Insiders	22.1%
Shares Institutions	9.16%
Shares Out	693,217,261
Shares Qo Q	4.12%
Shares Yo Y	-0.16%

Metric	Value
Average Volume	24,803,873.6x
Bv Per Share	4.94
CAPEX	CNY -213.5M
Ch10y	53.84
Ch15y	304.8
Ch1m	10.65
Ch1w	-0.84
Ch1y	-23.82
Ch3m	-6.5
Ch3y	29.95
Ch5y	86.26
Ch6m	-16.39
Change	2.95%
Change From Open	4.79
Close	14.23
Days Gap	-1.76
Depreciation Amortization	76,586,100
Dollar Volume	108,845,236.9
Earnings Date	2026-08-28
EBIT	CNY 778.4M
EBITDA	CNY 855M
EPS	CNY 0.94
F Score	5
FCF	CNY 355.8M
FCF EV Yield	3.56x
FCF Per Share	CNY 0.51
Financing CF	-186,199,984
Fiscal Year End	December
Founded	1,995
Goodwill	321,365,851
Graham Number	10.20272
Graham Upside	-28.3
Income Tax	CNY 118.5M
Investing CF	-385,093,194
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2015-05-20
Last Split Type	Forward
Lynch Fair Value	CNY 23.41
Lynch Upside	64.54
Ma150	15.46
Ma150ch	-7.96%
Ma20	14.18
Ma20ch	0.39%
Net CF	-2,045,801
Next Earnings Date	2026-08-28
Open	13.98
P FCF Ratio	27.73
P OCF Ratio	17.33
Payment Date	2026-05-28
Position In Range	98.53
Ppne	1,483,974,359
Price Date	2026-07-30
Price EBITDA	CNY 11.54
Ptbv Ratio	3.49
Relative Volume	0.3x
Revenue	3,114,135,556x
Tax By Revenue	3.8x
Tax Rate	15.2%
Tr6m	-14.28%
Volume	7,429,709
Z Score	5.59